dpp 4 inhibitors glp 1 GLP-1 receptor agonists or DPP-4 inhibitors: How to guide the clinician? A Comprehensive Review on Dipeptidyl

We help businesses stand out, scale up, and stay relevant.

Conclusions This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH

The future of obesity treatment will not depend only on discovering new molecules, but also on developing smarter and more patient-friendly ways to deliver them

Obesity management: Used widely for weight loss, even in non-diabetic individuals

While oral formulations offer the convenience of a pill compared to traditional injections, this shift also raises important compliance considerations